The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvacta Group Share News (AVCT)

Share Price Information for Avacta Group (AVCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 45.50
Bid: 45.00
Ask: 46.00
Change: -1.00 (-2.15%)
Spread: 1.00 (2.222%)
Open: 46.50
High: 45.50
Low: 45.00
Prev. Close: 46.50
AVCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK TRADING UPDATE SUMMARY: Virus Hits Mears But Tristel Gets Boost

Wed, 22nd Jul 2020 17:57

(Alliance News) - The following is a round-up of updates by London-listed companies issued on Wednesday and not separately reported by Alliance News:

----------

Mears Group PLC - services provider to the UK's housing sector - Expects revenue from continuing activities in the first half to June 30 to fall 7.7% annually to GBP405 million from GBP439 million. Expects a pretax loss on continuing activities and before the amortisation of acquisition intangibles to be around GBP6.0 million, swinging from a GBP16.7 million profit. Expects a recovery in activity in second half, assuming Covid-19 infection levels remain low.

----------

Tristel PLC - Cambridgeshire-based manufacturer of infection prevention products - Results for year ended June 30 will be ahead of market expectations, with revenue coming in at GBP31.6 million, a 21% increase, and adjusted pretax profit rising at the same rate to GBP6.8 million. During the final four months of the year when Covid-19 impact was it its greatest, sales rose 30% annually.

----------

Barkby Group PLC - owner of businesses in real estate, consumer & hospitality and life sciences sectors - Withdraws forecast of Ebitda of GBP3.5 million for year ended June 30, due to Covid-19. Also secures GBP1 million loan under UK's coronavirus business interruption scheme. Notes Commercial Property Development completed construction of Hastings development in June. Hospitality arm made "positive" start to 2020 before Covid-19 interruption.

----------

Itaconix PLC - polymers maker - Expects revenue growth of 80% to USD1.1 million in six months to June 30. Notes several customers have boosted size of recurring orders due to increased demand amid Covid-19.

----------

Boku Inc - US-based mobile payments solution provider - Revenue for six months to June 30 expected to be at least USD24.7 million, a rise of 5.1% from USD23.5 million reported a year ago. Annual earnings before interest, tax, depreciation, and amortisation are expected in line with expectations and 65% higher from 2019.

----------

MobilityOne Ltd - e-commerce infrastructure payment solutions and platform provider - Says 50%-owned remittance firm OneTransfer Remittance Sdn Bhd signs money transfer agreement with MoneyGram Payment Systems Inc. Agreement means OTR customers can send money on MoneyGram platform.

----------

Blancco Technology Group PLC - data erasure firm with a sales office in Hertfordshire - Despite Covid-19 lengthening sales cycles, performance in year to June 30 was in line with market expectations with revenue inching 9.5% higher to GBP33.4 million from GBP30.5 million. Adjusted operating profit tipped to rise 14% to GBP4.0 million.

----------

Cloudcall Group PLC - cloud-based software firm with offices in Leicester, Sydney and Boston, US - Says revenue in six months to June 30 up 11% annually to GBP5.8 million. Recurring subscriptions up 20% to GBP5.1 million and users up 19% to 43,815.

----------

Quixant PLC - Cambridge-based technology outsourcer for gaming industry - Says key gaming unit sees "minimal" order over past three months as most clients closed due to Covid-19. The Densitron business unit however, has "experienced healthy demand from a range of industrial sectors".

----------

Empresaria Group PLC - West Sussex-based staffing firm - Profitable in both quarters during the six months ended June 30, despite Covid-19. Second quarter net fee income plunged 39% annually, contributing to a 22% fall in the whole of the first half to GBP28.2 million from GBP36.3 million. Made cost savings however, second quarter expenses were 30% lower year-on-year, after the first quarter when they fell 23%.

----------

Anexo Group PLC - Liverpool-based legal services provider - Trading continuing in line with expectations and plans to reinstate financial guidance for 2020 in its August interim report. Note some staff in its Bond Turner legal services division are returning to office working as Covid-19 lockdowns ease.

----------

Avacta Group PLC - Wetherby-based biotherapeutics firm - To begin clinical validation of Covid-19 laboratory test being developed by US-based Adeptrix as part of a UK government scheme.

----------

Resolute Mining Ltd - gold miner with assets in Senegal and Mali - Gold poured in quarter ended June down 3.2% to 107,183 ounces from 110,763 ounces in March. On track for 430,000 ounces poured in 2020.

----------

Alba Mineral Resources PLC - mineral exploration and development company with gold asset in Wales - Notes work activity as resumed at Clogau gold project, Wales following Covid-19 lockdown. Says priority for summer 2020 is completing underground bulk sampling programme, upon receipt of regulatory consent.

----------

Pure Gold Mining Inc Canada-based gold mine developer - Ontario Ministry of the Environment, Conservation & Parks approves and issues amended environmental compliance approval for air and noise emissions at Red Lake mine.

----------

Danakali Ltd - potash miner - Reports that notice of commencement of mine development at Colluli asset accepted by Eritrean Ministry of Energy & Mines.

----------

Predator Oil & Gas Holdings PLC - Jersey-based oil and gas company - Has made an offer to acquire Columbus Energy Resources PLC's stake in Inniss-Trinity CO2 project in Trinidad. Predator has option acquire interest for USD4.2 million but Predator's offer totalled USD1.8 million, so Columbus rejected.

----------

Jangada Mines PLC - natural resources company with vanadium asset in Brazil - reports "overwhelming success" from drilling campaign at its Pitombeiras vanadium project, Brazil. Received final five assay results received from the Goela target at project.

----------

Bluejay Mining PLC - explorer with assets in Greenland and Finland - Says agreement with "multinational commodity trading firm" at Dundas ilmenite project has increased. Offtake pact up 50% to between 250,000 and 300,000 tonnes per year, extending agreement by three months to October 31.

----------

Great Western Mining Corp PLC - mineral explorer with gold project in Nevada - Notes initial work has begun at the Trafalgar Hill, West Ridge and Rhyolite Dome targets at the Olympic Gold project in Nevada.

----------

Gunsynd PLC - London-based investment firm - Invests AUD200,000, about GBP110,000, in Eagle Mountain Mining Ltd, a copper and gold explorer. Forms part of Eagle Mountain's AUD3.0 million wider fundraising. The funds will finance a surface diamond drilling programme at its Oracle Ridge copper mine project.

----------

Dekel Agri-Vision PLC - West African focused agriculture company - Reports milling equipment for a cashew processing plant it is developing in Cote d'Ivoire has arrived at port of Abidjan from Italy as planned.

----------

Altus Strategies PLC - mining royalty firm - Reports preliminary economic assessment at Diba gold project, Mali. Reports a pretax net present value of USD115 million and a post-tax net present value of USD81 million.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
5 Apr 2023 12:51

Avacta doses first patient in higher-dose oncology cohort

(Sharecast News) - Life sciences company Avacta Group announced that it had dosed the first patient in the fifth cohort of the first-in-human phase one trial of its innovative oncology drug 'AVA6000' on Wednesday.

Read more
5 Apr 2023 12:12

Avacta doses first patient in fifth cohort of AVA6000 phase 1 study

(Alliance News) - Avacta Group PLC on Wednesday said the first patient has been dosed in the fifth cohort of the first-in-human phase 1 trial of AVA6000, a novel form of doxorubicin designed to improve its safety and therapeutic index.

Read more
27 Mar 2023 13:44

Avacta to present tumour medicine data at cancer research meeting

(Sharecast News) - Life science company Avacta Group announced on Monday that it will present a poster on its novel 'preCISION' medicine, 'AVA3996', at the American Association for Cancer Research (AACR) 2023 annual meeting in Florida on 16 April.

Read more
13 Mar 2023 12:18

SUMMARY: London listings with exposure to Silicon Valley Bank

(Alliance News) - The following is a round-up of updates on exposure to Silicon Valley Bank by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
13 Mar 2023 10:08

Avacta has 'no relationship' with failed tech-focussed bank

(Sharecast News) - Life science company Avacta reassured the market on Monday, following the collapse of technology and science-focussed Silicon Valley Bank last week.

Read more
17 Jan 2023 17:16

Avacta reports positive progress in chemotherapy trial

(Sharecast News) - Oncology drug and diagnostics developer Avacta Group said in an update on Tuesday that 'AVA6000' was continuing to show a "very favourable" safety profile in the fourth dose cohort of the ALS-6000-101 dose escalation phase-one clinical trial.

Read more
17 Jan 2023 16:23

TRADING UPDATES: hVIVO wins contract; Dev Clever cancels shares

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
8 Nov 2022 13:51

Avacta raises GBP64 million to finance Launch Diagnostics purchase

(Alliance News) - Avacta Group PLC on Tuesday closed its GBP2.0 million open offer of shares, bringing its total fundraise to GBP64.0 million.

Read more
18 Oct 2022 12:40

Avacta plans to raise GBP62 million; buys Launch Diagnostics

(Alliance News) - Avacta Group PLC on Tuesday announced a GBP62.0 million fundraise, which will be partially used to finance its acquisition of Launch Diagnostics Holdings Ltd for up GBP37 million.

Read more
18 Oct 2022 11:12

Avacta buying Launch Diagnostics for initial £24m

(Sharecast News) - Clinical-stage oncology drug company Avacta has conditionally agreed to acquire Launch Diagnostics, it announced on Tuesday, for an upfront cash consideration of £24m on a debt-free, cash-free basis.

Read more
29 Sep 2022 11:56

Avacta losses narrow as it progresses clinical programmes

(Sharecast News) - Clinical-stage oncology drug developer Avacta reported first-half revenue of £5.5m on Thursday, up from £1.5m year-on-year and from £2.9m for the full 2021 period.

Read more
29 Sep 2022 11:30

Avacta narrows loss, multiplies revenue thanks to Therapeutics divison

(Alliance News) - Avacta Group PLC on Thursday reported a narrowed interim loss as it multiplied its revenue significantly thanks to a strong performance from its Therapeutics division.

Read more
5 Sep 2022 11:07

AIM WINNERS & LOSERS: Avacta gets approval; Jubilee's Roan at capacity

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
5 Sep 2022 10:10

Avacta shares up as drug approved for soft tissue sarcoma treatment

(Alliance News) - Avacta Group PLC on Monday said it received approval for its AVA6000 for treatment of soft tissue sarcoma.

Read more
5 Sep 2022 07:16

Avacta's soft tissue sarcoma treatment gets FDA orphan drug designation

(Sharecast News) - Biotechnology company Avacta Group said on Monday that its soft tissue sarcoma treatment has been granted orphan drug designation by the US Food and Drug Administration.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.